foto
LATEST NEWS

OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S



WEBCAST HALF-YEAR RESULTS 2011

Click here to access the webcast of 29 July 2011



OCTOPLUS ANNUAL REPORT 2010
OCTO SHARE PRICE
HOME dashNL dash CONTACT
februari 4, 2012

 

ONLY FOR DUTCH RESIDENTS

The Shares are being offered and sold only outside the Unites States, in reliance on Regulations S (“Regulation S”) under the Securities Act, to investors that are not “US Persons” as defined in Regulation S. Accordingly, subject to certain exceptions, the Shares may not be offered or sold outside the Netherlands, and the information in relation to the Private Placement may not be forwarded or transmitted in or into any country outside the Netherlands. Receipt of information in relation to the Private Placement does not constitute an invitation or offer to purchase the Shares in any country outside the Netherlands.

I am a resident of the Netherlands
I am not a resident of the Netherlands
Continue